Dandelion Bio ( SOSV Accelerator)

Funding Details
Awarder
SOSV
Date Award
June 10, 2024
Vertical
Biotech
Funding URL
View Funding Page

Company Info
Traction
Dandelion Bio has made significant progress in its research efforts, with promising results in preclinical studies. The company is actively engaging with potential partners and investors to support the advancement of its pipeline.
Organizations Involved
SOSV
Founders
Founders not specified
Company Description
Dandelion Bio is a biotech company focused on developing innovative therapies for various diseases. They leverage cutting-edge technologies to advance drug discovery and improve patient outcomes.
Market
Healthcare
Location
San Francisco, CA, US
Coinvestors
None

Links
Back to Home Back to Biotech Deals View Funding Announcement